產(chǎn)品詳情
簡單介紹：
Anti-ATG18抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-ATG18抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-ATG18
Cat. Number:
Anti-ATG18抗體XY-3871R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Members of the Anti-ATG18抗體WIPI subfamily of WD40 repeat proteins, such as WIPI1 (WD repeat domain, phosphoinositide interacting 1), have a 7-bladed propeller structure and contain a conserved motif for interaction with phospholipids. WIPI1 moved through the same set of endosomal membranes as that followed by mannose-6-phosphate receptor (MPR). Consistent with this, WIPI1 was enriched in clathrin-coated vesicles. Overexpression of WIPI1 disrupted the function of the MPR pathway, whereas expression of a double point mutant unable to bind phosphoinositides had no effect. Suppression Anti-ATG18抗體of WIPI1 by interfering RNA indicated that WIPI1 is required for normal endosomal organization and distribution of IGF2R.
Also known as:
ATG 18; ATG18; Anti-ATG18抗體Atg18 protein homolog; ATG18A; WD repeat domain phosphoinositide interacting 1; WD repeat domain phosphoinositide interacting protein 1; WD40 repeat protein interacting with phosphoInositides of 49kDa; WIPI 1 alpha; WIPI 1; WIPI 49; WIPI 49 kDa ; WIPI49.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Pig, .
●
Immunogen: KLH conjugated synthetic peptide derived from mouse WIPI1.
●
Predicted MolecularAnti-ATG18抗體 Weight: 49kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
xy-13492R GORASP2高爾基體磷蛋白6抗體
xy-13493R GOSR1高爾基SNAP受體復(fù)合物1抗體
xy-13494R GOT1L1谷氨酸草酰乙酸轉(zhuǎn)氨酶1樣蛋白1抗體
xy-13539R GPR52G蛋白偶聯(lián)受體52抗體
xy-13495R GP210核膜糖蛋白210抗體
xy-8875R GADD153GADD153抗體
xy-13540R GPR57G蛋白偶聯(lián)受體57抗體
xy-12435R FRAT2GSK-3結(jié)合蛋白FRAT2抗體
xy-10223R phospho-gamma Adducin (Ser693)磷酸化內(nèi)收蛋白gamma抗體
xy-13284R GAPT生長因子受體結(jié)合適應(yīng)蛋白抗體
xy-13285R GARNL3GARNL3蛋白抗體
xy-13286R GARNL1Tuberin樣蛋白1抗體
xy-13287R GARSX連鎖Charcot-Marie-Tooth神經(jīng)病變相關(guān)蛋白抗體
xy-13288R GART甘氨酰胺核苷酸合成酶抗體
xy-13289R GAS2生長休止特定蛋白2抗體
xy-13467R GNG11G蛋白γ11/Gγ11 抗體
xy-13358R phospho-Girdin (Tyr1765)磷酸化肌動(dòng)蛋白結(jié)合蛋白Girdin抗體
xy-13351R GGT7 heavy chainγ-谷氨酰轉(zhuǎn)肽酶7重鏈抗體
xy-13354R GH2生長**2/胎盤特異性生長**抗體
xy-13356R Giantin高爾基體相關(guān)蛋白GM130抗體
xy-13292R GIPR胃泌素抑制肽受體抗體
xy-10078R GM-CSFR alpha粒細(xì)胞-巨噬細(xì)胞集落刺激因子受體α抗體
xy-2735R GSTP1谷胱甘肽硫轉(zhuǎn)移酶pi基因抗體
xy-2885R Gab2接頭蛋白Gab 2抗體
xy-4044R Glucose 6 phosphatase alpha葡萄糖6磷酸酶α/G6Pase-α抗體
xy-4126R GPI糖磷脂酰肌醇抗體
xy-5131R GLO1乙二醛酶1抗體
xy-5140R GABPB2核呼吸因子2抗體
xy-5116R GDIA1腫瘤轉(zhuǎn)移抑制基因GDIA1抗體
xy-5126R D4 GDI腫瘤轉(zhuǎn)移抑制基因GDIA2抗體
xy-3796R Glucagon胰高血糖素抗體
